The cancer institute of the Saint-Luc university hospital in Brussels, the teaching hospital of UCLouvain opened in 1976, and a full member of the Organisation of European Cancer Institutes.
The Institut Roi Albert II is the cancer and haematology institute of the Cliniques universitaires Saint-Luc in Woluwe-Saint-Lambert, Brussels, the university hospital of UCLouvain that opened in 1976. It brings the hospital's oncology, haematology, radiotherapy and surgical cancer services together with the university's research groups. It is a full member of the Organisation of European Cancer Institutes (OECI); its representative on the OECI list is Philippe Leroy.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Cliniques Universitaires Saint-Luc, including child institutions. 342 works · 4,184 citations · 80% open access · 18% clinical trials · 2% reviews.
Brussels oncologist who led KEYNOTE-412, the trial that tested adding pembrolizumab to chemoradiotherapy for locally advanced head and neck cancer.
Philippe Leroy represents the King Albert II Cancer Institute of Cliniques universitaires Saint-Luc in the Organisation of European Cancer Institutes, which lists the centre among its full members in Belgium.